Catalyst Pharmaceuticals Inc (CPRX)
21.47
-0.44
(-2.01%)
USD |
NASDAQ |
Dec 27, 16:00
21.45
-0.02
(-0.09%)
After-Hours: 20:00
Catalyst Pharmaceuticals Research and Development Expense (Quarterly): 3.284M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ADMA Biologics Inc | 0.412M |
| Corcept Therapeutics Inc | 59.34M |
| Vertex Pharmaceuticals Inc | 875.90M |
| Sarepta Therapeutics Inc | 224.48M |
| Regenxbio Inc | 54.43M |